Bionano Genomics has received a consensus rating of Buy. The company’s average rating score is 3.00, and is based on 3 buy ratings, no hold ratings, and no sell ratings.
Similarly, Is BNGO good stock?
Based on his analysis, DeGeeter rates BNGO stock as « outperform » with a $14 value. Other analysts are also bullish on the company. Those tracked by the Wall Street Journal have BNGO rated as a consensus « buy » with an average $12 price target.
Is BNGO a US stock? BNGO:USNASDAQ CM. Bionano Genomics Inc.
Thereof, What type of stock is BNGO?
Common Stock (BNGO)
Who owns Bionano Genomics?
Top 10 Owners of Bionano Genomics Inc
| Stockholder | Stake | Shares owned |
|---|---|---|
| BlackRock Fund Advisors | 5.74% | 16,609,007 |
| The Vanguard Group, Inc. | 4.86% | 14,064,639 |
| SSgA Funds Management, Inc. | 2.49% | 7,198,880 |
| Geode Capital Management LLC | 1.63% | 4,714,883 |
Is BNGO a pump and dump?
BNGO stock has suffered at the hands of a Ritalin-using pump and dump scheme making waves in 2021.
How many shares are there of BNGO?
BioNano Genomics Inc (US:BNGO) has 292 institutional owners and shareholders that have filed 13D/G or 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 83,218,166 shares.
What is BNGO target price?
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +258.85% increase from the last price of 2.09.
What institutions are buying NIO?
Largest shareholders include Baillie Gifford & Co, BlackRock Inc., Vanguard Group Inc, State Street Corp, VWIGX – Vanguard International Growth Fund Investor Shares, Susquehanna International Group, Llp, Goldman Sachs Group Inc, Citadel Advisors Llc, VEIEX – Vanguard Emerging Markets Stock Index Fund Investor Shares, …
Is BNGO expected to rise?
Bionano Genomics Inc (NASDAQ:BNGO)
The 4 analysts offering 12-month price forecasts for Bionano Genomics Inc have a median target of 7.50, with a high estimate of 14.00 and a low estimate of 6.00. The median estimate represents a +253.77% increase from the last price of 2.12.
Will BNGO get FDA approval?
The Food and Drug Administration has not yet approved the device for use as a medical diagnostic tool in the U.S. However, healthcare entities can still use it for research purposes. The lack of FDA approval has also not hindered sales of the Saphyr in other countries.
Does Ark invest in BNGO?
Does ARK Invest in BNGO: The Bottom Line. At this time, ARK does not invest in BNGO. With that said, the company does appear to have some promise in its own right. Like all speculative small-cap companies, Bionano Genomics is a risky stock to own.
How much cash does BNGO have?
Compare BNGO With Other Stocks
| Bionano Genomics Annual Cash on Hand (Millions of US $) | |
|---|---|
| 2020 | $38 |
| 2019 | $17 |
| 2018 | $17 |
| 2017 | $1 |
Is BNGO in Russell?
(Nasdaq: BNGO) announced today that it was added as a member of the US small-cap Russell 2000® Index, effective after the US market opens on Monday, June 28, 2021, as part of the 2021 Russell indexes reconstitution.
What is the short interest on BNGO?
Bionano Genomics currently has a short interest ratio of 5.0.
What does BNGO company do?
Company Description
The firm engages in the development and marketing of the Saphyr system, a platform for ultra-sensitive and ultra-specific structural variation detection that enables researchers and clinicians to accelerate the search for new diagnostics and therapeutic targets and to streamline cytogenetics.
How high does IDEX go?
IDEX stock hit a 2022 high of $1.44 in early January and a low of $0.87 later in the same month. In 2021 its stock price ranged from 88 cents to $5.53. In an interview with Capital.com, Vinod Jain, senior analyst at Aite-Novarica Group, said “the stock could see more volatility due to its current price point”.
What does Bionano genomics do?
Bionano Genomics, Inc. provides a platform to analyze the long segments of genomic DNA and other biomolecules structural variations. The Company offers proprietary nanochannel chips, automated imaging instrument, integrated primary and secondary software, and application specific reagents.
Who is the biggest investor in NIO?
Top 10 Owners of NIO Inc
| Stockholder | Stake | Total value ($) |
|---|---|---|
| BlackRock Fund Advisors | 2.99% | 915,727,477 |
| The Vanguard Group, Inc. | 2.76% | 844,953,786 |
| SSgA Funds Management, Inc. | 2.45% | 751,155,776 |
| Goldman Sachs & Co. LLC (Private … | 1.73% | 529,951,450 |
Who is in the vanguard group?
Vanguard offers two classes of most of its funds: investor shares and admiral shares.
…
The Vanguard Group.
| Type | Privately held company |
|---|---|
| Key people | Mortimer J. Buckley (Chairman & CEO) |
| Products | Mutual funds Exchange-traded funds Broker Asset management Sub-advisory services |
| Revenue | $6.936 billion (2020) |
| AUM | $7.1 trillion (2020) |
Does Vanguard own NIO stock?
The top institutional shareholders of NIO are Originalwish Ltd., Tencent Holdings Ltd., Baillie Gifford & Co., BlackRock Inc. (BLK), and Vanguard Group Inc. Because NIO is a foreign company, it doesn’t file Form 4s for its individual insider shareholders.
What is Nio price target?
The 29 analysts offering 12-month price forecasts for NIO Inc have a median target of 32.94, with a high estimate of 86.57 and a low estimate of 24.08. The median estimate represents a +67.62% increase from the last price of 19.65.
Why does Bionano have tremendous potential?
The Bottom Line on BNGO Stock
Saphyr allows diseases to be more effectively researched than competing products. And, it is tremendously cheaper than other genomic-mapping tools. But it could also more successfully determine patients more susceptible to severe cases of viruses. These viruses include Covid-19.
What is a Bionano chip?
Built using proprietary Nanochannel technology, Bionano Chips for the Saphyr® and Irys® systems linearize DNA, enabling high-speed, high-throughput optical genome mapping and structural variation detection for a variety of applications including human and clinical research.
Join TheMoney.co community and don’t forget to share this post !
